Sociedad Americana de Hirudoterapia

Ethnikós Organismós Farmákon — National Organisation for Medicines

EOF · Greece · europe

Regulatory jurisdiction profileJurisdictional reference
Unregulatednational regulator

Greek national medicines agency under the Ministry of Health — leech-specific regulatory pathway has not been independently verified by ASH; medicinal leeches fall under the general EU MDR framework as appropriate.

Regulatory Profile

Agency type
national regulator
Region
europe
Country
Greece
Leech status
unregulated
Last ASH review
2026-05-26

Relevant Regulation Codes

  • Greek national medical-device implementing legislation for Regulation (EU) 2017/745 (MDR)
  • Greek national pharmaceutical law

Prescriber Requirements

  • Greek-licensed physician (ιατρός) authorised by the Hellenic Medical Association — order required for any medical-device application
  • Allied health professional application under physician supervision per institutional protocol

Supply Chain & GMP

Distributors operate under EU MDR Article 14 economic-operator obligations; standard cold-chain conditions for live invertebrates. Greek-language IFU.

Import/Export Rules

Intra-EU free circulation as per Regulation (EU) 2017/745. Third-country imports also require CITES Appendix II paperwork for Hirudo medicinalis / verbana.

Reimbursement Context

Not covered under public insurance schemes for leech therapy specifically.

ASH Editorial Notes

Leech-specific pathway not independently verified by ASH; falls under general medical device / traditional medicine framework as appropriate. Greek regulatory practice for live-organism medical devices follows EU MDR with national-level competent authority oversight by EOF.

Related Jurisdictions

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.